BUSINESS

• Arcalis Sees Opportunities in mRNA Drugs, Eyes Tens of Billions of Yen in CDMO Sales
  July 19, 2021

• GHIT Fund to Bankroll 97 Million Yen in TB Drug Discovery Project
  July 16, 2021

• Nichi-Iko to Cease Marketing of 9 Products Including Teva Takeda Drugs
  July 15, 2021

• Nippon Shinyaku Sues Sarepta over DMD Therapy Patents in US
  July 15, 2021

• Guilty Ruling for Ono Employees Now Final and Binding: Onoact Case
  July 15, 2021

• Takeda Expecting Delay in Entyvio Biosimilar Entry in Europe: CFO
  July 14, 2021

• Shionogi to Support Access to Cefiderocol in Low/Middle-Income Nations
  July 14, 2021

• Eisai Taps Continuous Manufacturing for Tazverik, Eyes Its Use for Other Oncology Assets Too
  July 14, 2021

• Astellas/Affinivax Pneumococcal Vaccine Delivers in PII, Gets Breakthrough Therapy Tag
  July 14, 2021

• Takeda’s Takhzyro Adds Long-Term Efficacy Data on HAE Attack Reduction
  July 14, 2021

• Xarelto Dry Syrup Now Available in Japan: Bayer
  July 13, 2021

• Astellas/Seagen’s ADC Padcev Snags Full Approval, Label Expansion
  July 13, 2021

• Sanofi/GSK COVID-19 Vaccine Enters PIII in Japan
  July 13, 2021

• Teijin Restricting Shipments for Onealfa after Curbs on Edirol
  July 13, 2021

• Towa’s Shipment Control List Expands to 241 Products; 7 Added
  July 13, 2021

• Pfizer R&D, NTT Data to Collaborate with NCC for Efficient Clinical Research
  July 12, 2021

• Enhertu PIII Begins for 2nd Line Use in HER2-Positive Gastric Cancer
  July 12, 2021

• Chugai, Alebund Ink Option and License Pact for Hyperphosphatemia Drug
  July 12, 2021

• Otsuka Files Auto-Injector Version of Migraine Drug Ajovy
  July 9, 2021

• 1,600 Vaccine Doses Ruined at Chugai Due to Flawed Temperature Control
  July 9, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 223
• 224
• 225
• 226
• 227
• 228
• 229
• 230
• 231
• …
• Next ›
• 最終 »